Thursday, September 23, 2021
Skyscraper...
Indictment...
More than half a dozen contractors were indicted for trying to score lucrative contracts by bribing supervisors at public housing developments in Brooklyn and Queens, officials announced Monday.
“The residents of NYCHA often live in conditions that are deplorable,” said Brooklyn District Attorney Eric Gonzalez at a press conference, referring to the embattled New York City Housing Authority. “This kind of brazen bribery cannot be accepted. This cannot be the way business is done. The residents of NYCHA deserve so much better.”
The DA and the city’s Department of Investigation announced at the joint press conference the takedown of nine contractors — Lakhwinder Kumar, Charanjit Singh, Satbir Singh, Davinder Singh, Nishan Singh, Surinder Singh, Guriqbal Singh, Jaswant Banga Singh and Bakhshish Chand.
Where does the tax money go? NYC budget of a 100 Billion Dollars ends up evaporated. Still the Democrats want to tax people some more. NYSHA, Homeless, MTA, Sewer, roads, ..etc
Just a thought
Muscles...
Loss of muscle mass and function (sarcopenia) may result from both acute and chronic diseases and, as in a vicious cycle, deeply impacts short- and long-term clinical outcomes.
These chronic conditions are often associated with sarcopenia in older individuals. It is therefore possible that sarcopenia itself is a risk factor for SARS-CoV-2 infection and critical illness.
It should also be highlighted that COVID-19, especially in its severe forms, involves marked elevation in inflammatory cytokines and prolonged immobilization, and is in fact associated with clinically significant weight loss.
Thus, sarcopenia may be a risk factor for COVID-19, while at the same time, COVID-19 infection and subsequent hospitalization may be an underestimated driver of cachexia and sarcopenia. Despite the potential clinical relevance of sarcopenia in COVID-19, little evidence is available in the literature to date.
Wednesday, September 22, 2021
Disparity...
The latest study, published in The New England Journal of Medicine, evaluated the real-world effectiveness of the vaccines at preventing symptomatic illness in about 5,000 health care workers in 25 states. The study found that the Pfizer-BioNTech vaccine had an effectiveness of 88.8 percent, compared with Moderna’s 96.3 percent.
Research published by the Centers for Disease Control and Prevention found that the efficacy of the Pfizer-BioNTech vaccine against hospitalization fell from 91 percent to 77 percent after a four-month period following the second shot. The Moderna vaccine showed no decline over the same period.
If the efficacy gap continues to widen, it may have implications for the debate on booster shots.
Scientists who were initially skeptical of the reported differences between the Moderna and Pfizer-BioNTech vaccines have slowly become convinced that the disparity is small but real.
“Our baseline assumption is that the mRNA vaccines are functioning similarly, but then you start to see a separation,” said Natalie Dean, a biostatistician at Emory University in Atlanta. “It’s not a huge difference, but at least it’s consistent.”
The discrepancy is not small and the real-world consequences uncertain, because both vaccines are still highly effective at preventing severe illness and hospitalization, she and others cautioned.
The question is where is Moderna and why is not approved? Just a thought.
Badder...
Factors...
Jobs are one reason why young adults are vulnerable to coronavirus infection. Many people in their 20s and 30s work in health care, food and essential services such as public transportation.
ZZZ.....
President Joe Biden announced Thursday that he had informed Congress he was rescinding the national emergency declaration on the U.S.-Mexico border that was put in place by former President Donald Trump in February 2019 to redirect billions of dollars for construction of a wall along the southern border.